Sunday, September 8

Browsing: Blueprint Medicines Corporation

Blueprint Medicines' Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH Annual Meeting

Health December 10, 2023

— HARBOR Part 1 trial data in indolent systemic mastocytosis showed elenestinib was well-tolerated with broad symptom improvement, supporting further…

Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Health August 6, 2023

CAMBRIDGE, Mass., Aug. 4, 2023 /PRNewswire/ — Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective August 1, 2023, the…

Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting

Health June 3, 2023

— Breadth of pipeline featured in multiple early clinical data presentations, reflecting diversity of fundamental growth drivers across development programs…

Blueprint Medicines Presents Registrational Data from PIONEER Trial of AYVAKIT® (avapritinib) in Patients with Indolent Systemic Mastocytosis at 2023 AAAAI Annual Meeting

Health February 27, 2023

— AYVAKIT achieved a statistically significant and clinically meaningful improvement in total symptom score that deepened over time, with improvements…

What's Hot

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

Browsing: Blueprint Medicines Corporation

Blueprint Medicines' Leadership in Driving Continued Innovation in Systemic Mastocytosis Highlighted at 2023 ASH Annual Meeting

Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual Meeting

Blueprint Medicines Presents Registrational Data from PIONEER Trial of AYVAKIT® (avapritinib) in Patients with Indolent Systemic Mastocytosis at 2023 AAAAI Annual Meeting

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

smartBreakfast Series 2024: llamada de atención para 2027

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

Must Watch

Levy Konigsberg Files Lawsuit on Behalf of 50 Men Who Were Sexually Abused as Juveniles at the New Jersey Training School

First Responders Action Group and The Independence Fund to Present All-Terrain Tracked Wheelchair to Former Las Vegas Law Enforcement Officer

SmartDry System Utilizes Secure AI Technology to Optimize Spray Drying

What's Hot

Browsing: Blueprint Medicines Corporation

Subscribe to Updates